.png)
Preventive Vaccines Market by Product Type and Application- Global Industry Analysis & Forecast to 2027
Published On : November 2020 Pages : 155 Category: Pharma & Healthcare Report Code : HC1113493
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Preventive Vaccines Market By Product Type (Live, Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines And Recombinant Vector Vaccines) and Application (Paediatric And Adult Vaccines)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Preventive Vaccines Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Preventive Vaccines produce antibodies that neutralize a disease-causing virus or bacterium. Thus vaccinated people are much less likely to become infected and transmit those germs to others. The higher the proportion of vaccinated people in a community, the lower the likelihood that a susceptible person will come into contact with an infectious individual.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Preventive Vaccines Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- AstraZeneca PLC
- Emergent BioSolutionsInc
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Preventive Vaccines Market, ByProductType, Estimates and Forecast, 2017-2027 ($Million)
o Live, Attenuated Vaccines
o Inactivated Vaccines
o Toxoid Vaccines
o Subunit Vaccines
o Conjugate Vaccines
o DNA Vaccines And Recombinant Vector Vaccines
· Preventive Vaccines Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Paediatric
o Adult Vaccines
· Preventive Vaccines Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o AstraZeneca PLC
o Emergent BioSolutionsInc
o GlaxoSmithKline PLC
o Johnson & Johnson
o Merck & Co
· Preventive Vaccines Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Preventive Vaccines Market, By Country
o U.S. Preventive Vaccines Market
o Canada Preventive Vaccines Market
o Mexico Preventive Vaccines Market
o Europe
§ Europe Preventive Vaccines Market, By Country
o UK Preventive Vaccines Market
o Germany Preventive Vaccines Market
o France Preventive Vaccines Market
o Russia Preventive Vaccines Market
o Italy Preventive Vaccines Market
o Rest of Europe Preventive Vaccines Market
o Asia-Pacific
§ Asia-Pacific Preventive Vaccines Market, By Country
o China Preventive Vaccines Market
o Japan Preventive Vaccines Market
o South Korea Preventive Vaccines Market
o India Preventive Vaccines Market
o Southeast Asia Preventive Vaccines Market
o Rest of Asia-Pacific Preventive Vaccines Market
o South America
§ South America Preventive Vaccines Market
o Brazil Preventive Vaccines Market
o Argentina Preventive Vaccines Market
o Columbia Preventive Vaccines Market
o Rest of South America Preventive Vaccines Market
o Middle East and Africa
§ Middle East and Africa Preventive Vaccines Market
o Saudi Arabia Preventive Vaccines Market
o UAE Preventive Vaccines Market
o Egypt Preventive Vaccines Market
o Nigeria Preventive Vaccines Market
o South Africa Preventive Vaccines Market
o TurkeyPreventive Vaccines Market
o Rest of MEA Preventive Vaccines Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Preventive Vaccines Market, By Product Type
5.1. Introduction
5.2. Global Preventive Vaccines Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Preventive Vaccines Revenue and Revenue Share by Product Type (2017-2021)
5.3. Live, Attenuated Vaccines
5.3.1. Global Live, Attenuated Vaccines Revenue and Growth Rate (2017-2021)
5.4. Inactivated Vaccines
5.4.1. Global Inactivated Vaccines Revenue and Growth Rate (2017-2021)
5.5. Toxoid Vaccines
5.5.1. Global Toxoid Vaccines Revenue and Growth Rate (2017-2021)
5.6. Subunit Vaccines
5.6.1. Global Subunit Vaccines Revenue and Growth Rate (2017-2021)
5.7. Conjugate Vaccines
5.7.1. Global Conjugate Vaccines Revenue and Growth Rate (2017-2021)
5.8. DNA Vaccines And Recombinant Vector Vaccines
5.8.1. Global DNA Vaccines And Recombinant Vector Vaccines Revenue and Growth Rate (2017-2021)
6. Preventive Vaccines Market, By Applications
6.1. Introduction
6.2. Global Preventive Vaccines Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Preventive Vaccines Revenue and Revenue Share by Applications (2017-2021)
6.3. Paediatric
6.3.1. Global Paediatric Revenue and Growth Rate (2017-2021)
6.4. Adult Vaccines
6.4.1. Global Adult Vaccines Revenue and Growth Rate (2017-2021)
7. Preventive Vaccines Market, By Region
7.1. Introduction
7.2. Global Preventive Vaccines Revenue and Market Share by Regions
7.2.1. Global Preventive Vaccines Revenue by Regions (2017-2021)
7.3. North America Preventive Vaccines by Countries
7.3.1. North America Preventive Vaccines Revenue and Growth Rate (2017-2021)
7.3.2. North America Preventive Vaccines Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Preventive Vaccines by Countries
7.4.1. Europe Preventive Vaccines Revenue and Growth Rate (2017-2021)
7.4.2. Europe Preventive Vaccines Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Preventive Vaccines by Countries
7.5.1. Asia-Pacific Preventive Vaccines Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Preventive Vaccines Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Preventive Vaccines by Countries
7.6.1. South America Preventive Vaccines Revenue and Growth Rate (2017-2021)
7.6.2. South America Preventive Vaccines Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Preventive Vaccines by Countries
7.7.1. Middle East and Africa Preventive Vaccines Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Preventive Vaccines Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. AstraZeneca PLC
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Emergent BioSolutions Inc
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. GlaxoSmithKline PLC
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Johnson & Johnson
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Merck & Co
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
9. Preventive Vaccines Market Forecast (2022-2027)
9.1. Global Preventive Vaccines Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Preventive Vaccines Market Forecast by Regions (2022-2027)
9.2.1. North America Preventive Vaccines Market Forecast (2022-2027)
9.2.1.1. United States Preventive Vaccines Market Forecast (2022-2027)
9.2.1.2. Canada Preventive Vaccines Market Forecast (2022-2027)
9.2.1.3. Mexico Preventive Vaccines Market Forecast (2022-2027)
9.2.2. Europe Preventive Vaccines Market Forecast (2022-2027)
9.2.2.1. Germany Preventive Vaccines Market Forecast (2022-2027)
9.2.2.2. France Preventive Vaccines Market Forecast (2022-2027)
9.2.2.3. UK Preventive Vaccines Market Forecast (2022-2027)
9.2.2.4. Russia Preventive Vaccines Market Forecast (2022-2027)
9.2.2.5. Italy Preventive Vaccines Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Preventive Vaccines Market Forecast (2022-2027)
9.2.3. Asia-Pacific Preventive Vaccines Market Forecast (2022-2027)
9.2.3.1. China Preventive Vaccines Market Forecast (2022-2027)
9.2.3.2. Japan Preventive Vaccines Market Forecast (2022-2027)
9.2.3.3. Korea Preventive Vaccines Market Forecast (2022-2027)
9.2.3.4. India Preventive Vaccines Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Preventive Vaccines Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Preventive Vaccines Market Forecast (2022-2027)
9.2.4. South America Preventive Vaccines Market Forecast (2022-2027)
9.2.4.1. Brazil Preventive Vaccines Market Forecast (2022-2027)
9.2.4.2. Argentina Preventive Vaccines Market Forecast (2022-2027)
9.2.4.3. Columbia Preventive Vaccines Market Forecast (2022-2027)
9.2.4.4. Rest of South America Preventive Vaccines Market Forecast (2022-2027)
9.2.5. Middle East and Africa Preventive Vaccines Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Preventive Vaccines Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Preventive Vaccines Market Forecast (2022-2027)
9.2.5.3. Egypt Preventive Vaccines Market Forecast (2022-2027)
9.2.5.4. Nigeria Preventive Vaccines Market Forecast (2022-2027)
9.2.5.5. South Africa Preventive Vaccines Market Forecast (2022-2027)
9.2.5.6. Turkey Preventive Vaccines Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Preventive Vaccines Market Forecast (2022-2027)
9.3. Preventive Vaccines Market Forecast by Product Type (2022-2027)
9.3.1. Preventive Vaccines Forecast by Product Type (2022-2027)
9.3.2. Preventive Vaccines Market Share Forecast by Product Type (2022-2027)
9.4. Preventive Vaccines Market Forecast by Applications (2022-2027)
9.4.1. Preventive Vaccines Forecast by Applications (2022-2027)
9.4.2. Preventive Vaccines Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Preventive Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Preventive Vaccines Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Live, Attenuated Vaccines Revenue and Growth Rate (2017-2019)
Figure Global Inactivated Vaccines Revenue and Growth Rate (2017-2019)
Figure Global Toxoid Vaccines Revenue and Growth Rate (2017-2019)
Figure Global Subunit Vaccines Revenue and Growth Rate (2017-2019)
Figure Global Conjugate Vaccines Revenue and Growth Rate (2017-2019)
Figure Global DNA Vaccines And Recombinant Vector Vaccines Revenue and Growth Rate (2017-2019)
Table Global Preventive Vaccines Revenue and Revenue Share by Applications (2017-2019)
Figure Global Paediatric Revenue and Growth Rate (2017-2019)
Figure Global Adult Vaccines Revenue and Growth Rate (2017-2019)
Table Global Preventive Vaccines Revenue by Regions (2017-2019)
Figure North America Preventive Vaccines Growth Rate (2017-2019)
Figure North America Preventive Vaccines Revenue and Growth Rate (2017-2019)
Figure North America Preventive Vaccines by Countries (2017-2019)
Figure North America Preventive Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure United States Preventive Vaccines Growth Rate (2017-2019)
Figure United States Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Preventive Vaccines Growth Rate (2017-2019)
Figure Canada Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Preventive Vaccines Growth Rate (2017-2019)
Figure Mexico Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Preventive Vaccines Growth Rate (2017-2019)
Figure Europe Preventive Vaccines Revenue and Growth Rate (2017-2019)
Figure Europe Preventive Vaccines by Countries (2017-2019)
Figure Europe Preventive Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure Germany Preventive Vaccines Growth Rate (2017-2019)
Figure Germany Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Preventive Vaccines Growth Rate (2017-2019)
Figure France Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Preventive Vaccines Growth Rate (2017-2019)
Figure UK Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Preventive Vaccines Growth Rate (2017-2019)
Figure Russia Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Preventive Vaccines Growth Rate (2017-2019)
Figure Italy Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Preventive Vaccines Growth Rate (2017-2019)
Figure Rest of Europe Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Preventive Vaccines Growth Rate (2017-2019)
Figure Asia-Pacific Preventive Vaccines Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Preventive Vaccines by Countries (2017-2019)
Figure Asia-Pacific Preventive Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure China Preventive Vaccines Growth Rate (2017-2019)
Figure China Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Preventive Vaccines Growth Rate (2017-2019)
Figure Japan Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Preventive Vaccines Growth Rate (2017-2019)
Figure Korea Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Preventive Vaccines Growth Rate (2017-2019)
Figure India Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Preventive Vaccines Growth Rate (2017-2019)
Figure Southeast Asia Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Preventive Vaccines Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Preventive Vaccines Growth Rate (2017-2019)
Figure South America Preventive Vaccines Revenue and Growth Rate (2017-2019)
Figure South America Preventive Vaccines by Countries (2017-2019)
Figure South America Preventive Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Preventive Vaccines Growth Rate (2017-2019)
Figure Brazil Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Preventive Vaccines Growth Rate (2017-2019)
Figure Argentina Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Preventive Vaccines Growth Rate (2017-2019)
Figure Columbia Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Preventive Vaccines Growth Rate (2017-2019)
Figure Rest of South America Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Preventive Vaccines Growth Rate (2017-2019)
Figure Middle East and Africa Preventive Vaccines Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Preventive Vaccines by Countries (2017-2019)
Figure Middle East and Africa Preventive Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Preventive Vaccines Growth Rate (2017-2019)
Figure Saudi Arabia Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Preventive Vaccines Growth Rate (2017-2019)
Figure United Arab Emirates Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Preventive Vaccines Growth Rate (2017-2019)
Figure Egypt Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Preventive Vaccines Growth Rate (2017-2019)
Figure Nigeria Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Preventive Vaccines Growth Rate (2017-2019)
Figure South Africa Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Preventive Vaccines Growth Rate (2017-2019)
Figure Turkey Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Preventive Vaccines Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Preventive Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Table AstraZeneca PLC Preventive Vaccines Financial Overview
Table Emergent BioSolutions Inc Preventive Vaccines Financial Overview
Table GlaxoSmithKline PLC Preventive Vaccines Financial Overview
Table Johnson & Johnson Preventive Vaccines Financial Overview
Table Merck & Co Preventive Vaccines Financial Overview
Figure Global Preventive Vaccines Revenue (Millions USD) and Growth Rate (2019-2027)
Table Preventive Vaccines Market Forecast by Regions (2019-2027)
Figure North America Preventive Vaccines Market Forecast (2019-2027)
Figure United States Preventive Vaccines Market Forecast (2019-2027)
Figure Canada Preventive Vaccines Market Forecast (2019-2027)
Figure Mexico Preventive Vaccines Market Forecast (2019-2027)
Figure Europe Preventive Vaccines Market Forecast (2019-2027)
Figure Germany Preventive Vaccines Market Forecast (2019-2027)
Figure France Preventive Vaccines Market Forecast (2019-2027)
Figure UK Preventive Vaccines Market Forecast (2019-2027)
Figure Russia Preventive Vaccines Market Forecast (2019-2027)
Figure Italy Preventive Vaccines Market Forecast (2019-2027)
Figure Rest of Europe Preventive Vaccines Market Forecast (2019-2027)
Figure Asia-Pacific Preventive Vaccines Market Forecast (2019-2027)
Figure China Preventive Vaccines Market Forecast (2019-2027)
Figure Japan Preventive Vaccines Market Forecast (2019-2027)
Figure Korea Preventive Vaccines Market Forecast (2019-2027)
Figure India Preventive Vaccines Market Forecast (2019-2027)
Figure Southeast Asia Preventive Vaccines Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Preventive Vaccines Market Forecast (2019-2027)
Figure South America Preventive Vaccines Market Forecast (2019-2027)
Figure Brazil Preventive Vaccines Market Forecast (2019-2027)
Figure Argentina Preventive Vaccines Market Forecast (2019-2027)
Figure Columbia Preventive Vaccines Market Forecast (2019-2027)
Figure Rest of South America Preventive Vaccines Market Forecast (2019-2027)
Figure Middle East and Africa Preventive Vaccines Market Forecast (2019-2027)
Figure Saudi Arabia Preventive Vaccines Market Forecast (2019-2027)
Figure United Arab Emirates Preventive Vaccines Market Forecast (2019-2027)
Figure Egypt Preventive Vaccines Market Forecast (2019-2027)
Figure Nigeria Preventive Vaccines Market Forecast (2019-2027)
Figure South Africa Preventive Vaccines Market Forecast (2019-2027)
Figure Turkey Preventive Vaccines Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Preventive Vaccines Market Forecast (2019-2027)
Figure Global Preventive Vaccines Forecast by Product Type (2019-2027)
Figure Global Preventive Vaccines Market Share Forecast by Product Type (2019-2027)
Figure Global Preventive Vaccines Forecast by Product Type (2019-2027)
Figure Global Preventive Vaccines Forecast by Applications (2019-2027)
Figure Global Preventive Vaccines Market Share Forecast by Applications (2019-2027)
Figure Global Preventive Vaccines Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|